Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A bill filed in Springfield would allow doctors to prescribe some HIV medication without needing prior authorization.